Status:
UNKNOWN
Evaluation of Echocardiographic Indices and Blood Biomarkers in Group 1 Pulmonary Hypertension
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
* To evaluate different echocardiographic indices in diagnosis and follow up of group 1 pulmonary hypertension. * To evaluate blood biomarkers (troponin, uric acid and micro RNA) in naïve group 1 pulm...
Detailed Description
Introduction: Pulmonary hypertension is pathophysiological condition defined as increases of mean pulmonary artery pressure above 20 mmHg as assessed by right heart catheterization (RHC) (1). As pul...
Eligibility Criteria
Inclusion
- Age\>18 years old
- Patient diagnosed as group 1 PH.
Exclusion
- Age under 18 years.
- Unwilling or unable to sign the informed consent form.
- Hemodynamically unstable condition requiring inotropic or vasoactive drugs.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04279145
Start Date
March 1 2020
End Date
April 1 2023
Last Update
February 21 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.